लोड हो रहा है...

Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expression

Anorectal melanoma is a rare disease with a poor prognosis and its response to immunotherapy remains poorly studied. The current study reports a case of recurrent anorectal melanoma in a 60-year-old woman that has exhibited a durable response to ipilimumab for >2 years. Given that the combination...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mol Clin Oncol
मुख्य लेखकों: Sakai, Hitomi, Takeda, Masayuki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: D.A. Spandidos 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7366236/
https://ncbi.nlm.nih.gov/pubmed/32714542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2020.2048
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!